Skip to main content
Equibles

Deirdre Connelly

Board Member

Sarepta Therapeutics, Inc. (SRPT)

Equibles does not estimate personal net worth.

Get an email with a short summary when Sarepta Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get SRPT alerts

About Deirdre Connelly

Deirdre Connelly is recorded as Board Member at Sarepta Therapeutics, Inc. (SRPT) since January 1, 2024. The newest filing on record that lists Deirdre Connelly as Board Member at Sarepta Therapeutics, Inc. (SRPT) is dated April 24, 2026. Sarepta Therapeutics, Inc. reported in an 8-K filed June 4, 2026 a re-election or new board role (director) for Deirdre Connelly, on the board since at least 2024, effective June 4, 2026. Sarepta Therapeutics, Inc. reported in an 8-K filed September 16, 2024 that Deirdre Connelly was appointed director, effective September 12, 2024. Sarepta Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sarepta Therapeutics, Inc. includes Douglas Ingram (CEO and Board Member), Michael Severino, M.D. (CEO and Board Member), M. Kathleen Behrens (Chairman) and 7 others.

“The director nominees listed below were elected to serve on the Company’s board of directors as members of Class I for a term of two years.”
Sarepta Therapeutics, Inc. Form 8-K, filed June 4, 2026 · Read the filing
“On September 12, 2024, the board of directors (the "Board") of Sarepta Therapeutics, Inc. (the "Company") appointed Deirdre Connelly as a director of the Company, effective immediately, to serve as a member of Class I until the 2026 annual meeting of stockholders.”
Sarepta Therapeutics, Inc. Form 8-K, filed September 16, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Sarepta Therapeutics, Inc.

Recent activity